|
Title
|
|
|
|
SGLT2 inhibitors and GLP-1 receptor agonists : a sound combination
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| Management of type 2 diabetes has evolved from a glucocentric to a holistic and patient-oriented approach. The focus now is not only on lowering HbA1c concentration without hypoglycaemia and bodyweight gain but also on reducing cardiovascular and renal morbidity and mortality.1 An ideal combination of antidiabetes drugs should have complementary effects that correct the many pathophysiological effects of type 2 diabetes and be safe, durable, well tolerated, easy to administer, and cost-effective. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Lancet diabetes & endocrinology. - Amsterdam
|
|
|
Publication
|
|
|
|
New york
:
Elsevier science inc
,
2018
|
|
|
ISSN
|
|
|
|
2213-8587
|
|
|
DOI
|
|
|
|
10.1016/S2213-8587(18)30031-7
|
|
|
Volume/pages
|
|
|
|
6
:5
(2018)
, p. 349-352
|
|
|
ISI
|
|
|
|
000430631600003
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|